Psychedelics Optimi Health to supply MDMA for new psychedelic therapy program at Numinus clinics The experiential training will only be available through Numinus and will utilize the protocol of MAPS Rowan DunneJune 15, 2023
News NIH invests $1.5M in psychedelics research for substance use disorders Research teams can receive up to $700K for an initial two-year phase to develop their studies, followed by up to $500K per year for... Natalia Buendia CalvilloMay 19, 2023
Psychedelics Ohio State University gets DEA approval for psilocybin cultivation and research The research will be conducted with stringent regulations and guidelines Rowan DunneMay 19, 2023
Psychedelics Psyched Wellness Amanita muscaria extract shows potential for brain health improvement The study found that the extract activates specialized cells within the brain Rowan DunneMay 3, 2023
Psychedelics University of Exeter launches postgrad psychedelics certificate program The online program 'Psychedelics: Mind, Medicine, and Culture' was announced at the Breaking Convention conference last week Rowan DunneApril 28, 2023
Psychedelics MGC Pharma gets permission from Slovenian health authorities to research psilocybin MGC says it is the first company operating in Slovenia to obtain permission to engage in studies on the psychedelic compound Rowan DunneApril 5, 2023
Psychedelics Mindset Pharma develops patent-pending new technology Company announces development of novel intranasal formulation with promising efficacy Rowan DunneJune 30, 2022
Coming soon PAREA: A new psychedelic-focused alliance of prominent companies with common goals Multi-organization psychedelic partnership set to launch on June 23 Rowan DunneJune 16, 2022